RBC Bioscience Corporation (TPEX:6848)
Taiwan · Delayed Price · Currency is TWD 16.25
-0.25 (-1.52%)
Feb 11, 2026, 2:07 PM CST
RBC Bioscience Market Cap
RBC Bioscience has a market cap or net worth of 210.86 million as of February 13, 2026. Its market cap has decreased by -15.58% in one year.
Market Cap
210.86M
Enterprise Value
586.46M
Revenue
201.85M
Ranking
n/a
PE Ratio
11.91
Stock Price
16.25
Market Cap Chart
Since October 25, 2021, RBC Bioscience's market cap has decreased from 632.27M to 210.86M, a decrease of -66.65%. That is a compound annual growth rate of -22.53%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 11, 2026 | 210.86M | -3.56% |
| Dec 31, 2025 | 218.65M | -11.78% |
| Dec 31, 2024 | 247.83M | 17.90% |
| Dec 29, 2023 | 210.20M | 2.21% |
| Dec 30, 2022 | 205.66M | -55.24% |
| Dec 30, 2021 | 459.45M | -27.33% |
| Oct 25, 2021 | 632.27M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eusol Biotech | 1.05B |
| Taiwan Advance Bio-Pharmaceutical | 990.00M |
| TCI GENE | 986.90M |
| NatureWise Biotech & Medicals | 982.35M |
| Neith | 974.70M |
| SynCore Biotechnology Co.,Ltd | 771.87M |
| BioLASCO Taiwan | 761.96M |
| TaiwanJ Pharmaceuticals | 616.94M |